Skip to main content
Clinical Trials/NCT06444503
NCT06444503
Not Yet Recruiting
N/A

Creation of a Biological Collection to Study the Pathophysiology and Identify Predictive Factors for the Evolution of Bone, Calcium and Growth Plate Pathologies.

University Hospital, Toulouse1 site in 1 country350 target enrollmentAugust 2024
ConditionsBone Disorder

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bone Disorder
Sponsor
University Hospital, Toulouse
Enrollment
350
Locations
1
Primary Endpoint
Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologies
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies.

This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.

Registry
clinicaltrials.gov
Start Date
August 2024
End Date
August 2034
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children (from birth) with growth plate or bone pathology
  • Patients affiliated to or benefiting from a social security scheme
  • Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies :
  • mastery of the French language
  • Not being subject to a restriction of rights by the judicial authorities
  • Patients or legal representatives having given their consent to participate in the study (expression of non-opposition).

Exclusion Criteria

  • Patients under legal protection (guardianship, curatorship or safeguard of justice)
  • Pregnant or breast-feeding women

Outcomes

Primary Outcomes

Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologies

Time Frame: Day 0 and through study completion, an average of 5 years

Blood and urine sampling

Secondary Outcomes

  • Identification of potential markers of disease progression based on new knowledge.(Day 0 and through study completion, an average of 5 years)

Study Sites (1)

Loading locations...

Similar Trials